0 69

Cited 1 times in

Multi-institutional study of treatment patterns in Korean patients with WHO grade II gliomas: KNOG 15-02 and KROG 16-04 intergroup study

Authors
 Taeryool Koo  ;  Do Hoon Lim  ;  Ho Jun Seol  ;  Chul-Kee Park  ;  Il Han Kim  ;  Jong Hee Chang  ;  Jeongshim Lee  ;  Shin Jung  ;  Ho-Shin Gwak  ;  Kwan Ho Cho  ;  Chang-Ki Hong  ;  Ik Jae Lee  ;  El Kim  ;  Jin Hee Kim  ;  Yong-Kil Hong  ;  Hong Seok Jang  ;  Chae-Yong Kim  ;  In Ah Kim  ;  Sung Hwan Kim  ;  Young Il Kim  ;  Eun-Young Kim  ;  Woo Chul Kim  ;  Semie Hong 
Citation
 Journal of Neuro-Oncology, Vol.138(3) : 667-677, 2018 
Journal Title
 Journal of Neuro-Oncology 
ISSN
 0167-594X 
Issue Date
2018
Keywords
Low-grade glioma ; PCV ; Patterns of care ; Radiotherapy ; Temozolomide
Abstract
INTRODUCTION: We performed this study to identify the treatment patterns of patients with low-grade gliomas (LGG) in Korea. METHODS: A total of 555 patients diagnosed as WHO grade II gliomas between 2000 and 2010 at 14 Korean institutions were included. The patients were divided into four adjuvant treatment groups: adjuvant fractionated radiotherapy (RT, N = 204), adjuvant chemotherapy (N = 20), adjuvant fractionated RT and chemotherapy (N = 65), and non-adjuvant treatment (N = 266) groups. We examined differences among the groups and validated patient/tumor characteristics associated with the adjuvant treatments. RESULTS: Astrocytoma was diagnosed in 210 patients (38%), oligoastrocytoma in 85 patients (15%), and oligodendroglioma in 260 patients (47%). Gross total resection was performed in 200 patients (36%), subtotal resection in 153 (28%), partial resection in 71 patients (13%), and biopsy in 131 patients (24%). RT was most commonly applied as an adjuvant treatment. The use of chemotherapy with or without RT decreased after 2008 (from 38 to 4%). The major chemotherapeutic regimen was procarbazine, lomustine, and vincristine (PCV); however, the proportion of temozolomide increased since 2005 (up to 69%). Patient/tumor characteristics related with RT were male gender, non-seizure, multiple lobes involvement, and non-gross total resection. Chemotherapy was associated with non-gross total resection and non-astrocytoma. CONCLUSIONS: A preference for RT and increased use of temozolomide was evident in the treatment pattern of LGG. The extent of resection was associated with a decision to perform RT and chemotherapy. To establish a robust guideline for LGG, further studies including molecular information are needed.
Full Text
https://link.springer.com/article/10.1007%2Fs11060-018-2839-z
DOI
10.1007/s11060-018-2839-z
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Radiation Oncology (방사선종양학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Neurosurgery (신경외과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Ik Jae(이익재) ORCID logo https://orcid.org/0000-0001-7165-3373
Lee, Jeong Shim(이정심)
Chang, Jong Hee(장종희)
Hong, Chang Ki(홍창기)
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/162504
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse